Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

1 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

LC-MS-based urine metabolomics analyses for early diagnosis of medulloblastoma

ABSTRACT: we applied liquid chromatography - mass spectrometry (LC-MS) based metabolomics to analyze a cohort including 420 urine samples

ORGANISM(S): Homo Sapiens

SUBMITTER: Wei Sun

PROVIDER: PXD016453 | iProX | Wed Nov 27 00:00:00 GMT 2019

REPOSITORIES: iProX

ACCESS DATA

Json Xml

Similar Datasets

Urine Metabolomics and Colorectal Cancer Screening

Project description:This is a prospective, multi-centered study to assess whether urine metabolomics can play a role in the screening of colorectal cancer (CRC). Urine samples will be collected from 1000 patients going through an established CRC screening program, and from a further 500 patients who already have a diagnosis of CRC. Using nuclear magnetic resonance (NMR) spectroscopy, the 1H NMR spectrum of urine samples will be analyzed for specific metabolites, and establish the metabolomic signature of colorectal cancer. The results from metabolomic urinalysis of this screening cohort will be compared with results from colonoscopy, histological descriptions, fecal occult blood testing (FOBT), and fecal immune testing (FIT) to assess the accuracy of urine metabolomics in identifying patients with polyps and malignancies. The urine metabolomic results from the colorectal cancer group will be correlated with operative, histological and clinical staging to define the role of urine metabolomics in assessing colorectal cancer type, location and stage. Additionally approximately 300 urine samples from breast cancer patients and 300 from prostate cancer patients will be collected to validate that the colorectal cancer signature is unique.

| 2116822 | ecrin-mdr-crc

Monitoring advanced adenoma and early colorectal cancer by urine metabolomics

Project description:Interventions: Control Group:none;Advanced Adenoma Group:none;Early Colorectal Cancer Group:none Primary outcome(s): urine metabolomics Study Design: Factorial

| 2702218 | ecrin-mdr-crc

LC-MS-based urine metabolomics analysis of chronic subdural hematoma for biomarker discovery

Project description:A comprehensive liquid chromatography-mass spectrometry (LC-MS) based metabolomics was utilized to find the specific urine metabolites in a cohort to discriminate urine metabolome profiles, including healthy controls and patients with CSDH.

2022-11-21 | PXD038258 | iProX

Characterization of LC-MS based urine metabolomics in healthy children and adults

Project description:In this study, we provided a comprehensive lifespan characterization of urine metabolomics in a cohort of 348 healthy children and 315 adults aged 1 to 70 years using liquid chromatography coupled with high resolution mass spectrometry.

2022-06-06 | PXD034390 | iProX

Non-invasive diagnosis of urothelial cancer in urine using DNA hypermethylation signatures

Project description:Methylation status of free DNA from urine from patients with urothelial tumor and healthy control patients were analysed

2018-09-22 | GSE120288 | GEO

Urine miRNA transcriptome of prostate cancer patients [Discovery cohort]

Project description:Intra-individual stability of the urine miRNA transcriptome was examined by investigating longitudinal changes over time in a cohort of patients with localized prostate cancer. Using training and validation cohorts, urinary miRNA biomarkers are characterized and validated their utility to identify aggressive prostate cancer.

2019-10-24 | GSE104431 | GEO

Urine miRNA transcriptome of prostate cancer patients [Validation cohort]

2019-10-24 | GSE104430 | GEO

Urine miRNA transcriptome of prostate cancer patients [Training cohort]

2019-10-24 | GSE104429 | GEO

Urine

Project description:Urine Raw sequence reads

| PRJNA850668 | ENA

Microbiota and Metabolomics of Intestinal Type of Gastric Cancer

Project description:Compare with the gastric cavity without cancerous transformation in atrophic gastritis, analyze the microbiota and metabolomics changes in intestinal type of gastric cancer under the background of atrophic gastritis, and explore the relevant mechanisms.

| 108938 | ecrin-mdr-crc

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data